Portfolio of Diabetes Stocks

Here is a sample of 12 stocks that provide diabetes treatments and monitoring.

12 Diabetes Stocks

Stock Returns & Price Chart


Recent Prices &
Annualized Return

Abbott LaboratoriesABT
Eli LillyLLY
Insulet CorporationPODD
Lexicon PharmaceuticalsLXRX
MannKind Corp.MNKD
Novo NordiskNVO
Provention BioPRVB
Senseonics HoldingsSENS
Tandem Diabetes CareTNDM
Price data from Quandl as of most recent close.

To inspect the performance of the Diabetes Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Quandl.

The 10 stocks included in the portfolio computations are: ABT, AZN, DXCM, LLY, PODD, LXRX, MNKD, MDT, NVO and TNDM. The current value of the portfolio assumes that $1,000.00 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. PRVB and SENS were excluded from the portfolio computations because of insufficient price data.

The current value of a $10,000 investment is $16,260. The percent return is 62.60%. The annualized return is 10.21%.

Return Summary for Diabetes Stocks
Start DateJun-30-2014
Start Investment$10,000.00
End DateJun-17-2019
Current Value of Investment$16,260.25
Total Return62.60%
Annualized Return10.21%
Min DateNov-30-2016
Min Price$8,940.47
Max DateJun-17-2019
Max Price$16,260.25
# Values61
Number Returns1,830
Number Profitable Returns1,461
Percent Profitable Returns79.84%
Number Unprofitable Returns369
Percent Unprofitable Returns20.16%
Profitable to Unprofitable Returns Ratio3.96

NOTE: The stocks included in the tables and chart are representative of the industry. They are not recommendations.

Related Portfolios

Portfolio of Biotech Stocks

Portfolio of Dividend-Paying Pharmaceutical Stocks